PROVECTUS BIOPHARMACEUTICALS, INC. Note Agreements
14 Contracts & Agreements
- Form of Unsecured Convertible Promissory Note (Filed With SEC on July 17, 2024)
- Form of Unsecured Convertible Promissory Note (Filed With SEC on September 26, 2022)
- Form of Unsecured Convertible Promissory Note (Filed With SEC on August 18, 2021)
- Form of PRH 2 Secured Convertible Promissory Note (Filed With SEC on January 7, 2020)
- Secured Convertible Promissory Note between the Company and Edward V. Pershing, dated July 26, 2018 (Filed With SEC on July 30, 2018)
- First Amendment to Amended and Restated Secured Convertible Promissory Note between the Company and CAL Enterprises LLC, dated January 22, 2018 (Filed With SEC on May 9, 2018)
- Fourth Amendment to Amended and Restated Secured Convertible Promissory Note between the Company and Eric Wachter, Ph.D., dated January 22, 2018 (Filed With SEC on May 9, 2018)
- Third Amendment to Amended and Restated Secured Convertible Promissory Note between the Company and Eric Wachter, Ph.D., dated January 22, 2018 (Filed With SEC on May 9, 2018)
- Second Amendment to Amended and Restated Secured Convertible Promissory Note between the Company and Eric Wachter, Ph.D., dated January 22, 2018 (Filed With SEC on May 9, 2018)
- Convertible Promissory Note between the Company and Timothy C. Scott, dated February 23, 2018 (Filed With SEC on February 26, 2018)
- Secured Convertible Promissory Note between the Company and Eric A. Wachter, dated January 25, 2018 (Filed With SEC on January 30, 2018)
- AMENDED AND RESTATED SECURED CONVERTIBLE PROMISSORY NOTE (this Note) (Filed With SEC on April 4, 2017)
- SECURED CONVERTIBLE PROMISSORY NOTE (this Note) (Filed With SEC on April 4, 2017)
- CONVERTIBLE PROMISSORY NOTE (this Note) (Filed With SEC on February 21, 2017)
